COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,668 Articles (22,913 medRxiv, 8,755 bioRxiv)

Most recent first Previous |  Page 1872: Articles 18711-18720  | Next

Estimating vaccine confidence levels among future healthcare workers and their trainers: A quantitative study protocol
Oduwole, E. O., Mahomed, H., Ayele, B. T., Wiysonge, C. S.
10.1101/2021.02.03.21251068 — Posted: 2021-02-05
Mental Health, Substance Use, and Suicidal Ideation Among Unpaid Caregivers in the United States During the COVID-19 Pandemic: Relationships to Age, Race/Ethnicity, Employment, and Caregiver Intensity
Czeisler, M. E., Drane, A., Winnay, S. S., Capodilupo, E. R., Czeisler, C. A., Rajaratnam, S. M. W., Howard, M. E.
10.1101/2021.02.02.21251042 — Posted: 2021-02-05
Quantifying transmissibility of COVID-19 and impact of intervention within long-term health care facilities
Stockdale, J. E., Anderson, S. C., Edwards, A. M., Iyaniwura, S. I., Mulberry, N., Otterstatter, M. C., Janjua, N. Z., Coombs, D., Colijn, C., Irvine, M. A.
10.1101/2021.02.01.21249903 — Posted: 2021-02-05
Could the new COVID-19 mutant strain undermine vaccination efforts? A mathematical modelling approach for estimating the spread of the UK mutant strain using Ontario, Canada, as a case study
Betti, M., Bragazzi, N., Heffernan, J. M., Kong, J. D., Raad, A.
10.1101/2021.02.02.21251039 — Posted: 2021-02-05
Modulation of SARS-CoV-2 Spike-induced Unfolded Protein Response (UPR) in HEK293T cells by selected small chemical molecules
Balakrishnan, B., Lai, K.
10.1101/2021.02.04.429769 — Posted: 2021-02-04
Follow-up of a hospital cohort during the first 3,530 suspected cases of COVID-19 in Sao Jose do Rio Preto, Sao Paulo, Brazil
Pacca, C. C., Zini, N., Versiani, A., Lobl, E., Milhim, B., Campos, G., Moraes, M., dos Santos, T., Dourado, F., Moraes, B., Rocha, L., dos Santos, A., Ruiz, L., da Silva, G., Nicesio, R., Queiroz, F., Salomao, M. L., da Silva, N., Negri, A., Nogueira, M., Estofolete, C.
10.1101/2021.02.04.429711 — Posted: 2021-02-04
Codon arrangement modulates MHC-I peptides presentation: implications for a SARS-CoV-2 peptide-based vaccine
Daouda, T., Dumont-Lagace, M., Feghaly, A., Villani, A.-C.
10.1101/2021.02.04.429819 — Posted: 2021-02-04
Extensive recombination-driven coronavirus diversification expands the pool of potential pandemic pathogens
Goldstein, S. A., Brown, J., Pedersen, B. S., Quinlan, A. R., Elde, N. C.
10.1101/2021.02.03.429646 — Posted: 2021-02-04
Site-specific O-glycosylation analysis of SARS-CoV-2 spike protein produced in insect and human cells
Bagdonaite, I., Thompson, A. J., Wang, X., Soegaard, M., Fougeroux, C., Frank, M., Diedrich, J. K., Yates, J. R., Salanti, A., Vakhrushev, S. Y., Paulson, J. C., Wandall, H. H.
10.1101/2021.02.03.429627 — Posted: 2021-02-04
Large-scale analysis of SARS-CoV-2 spike-glycoprotein mutants demonstrates the need for continuous screening of virus isolates
Schroers, B., Gudimella, R., Bukur, T., Roesler, T., Loewer, M., Sahin, U.
10.1101/2021.02.04.429765 — Posted: 2021-02-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).